Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Novo Nordisk Affirms 25% Weight-loss Expectation for Experimental Drug CagriSema
LONDON (Reuters) -Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 drugs already on the market, and reiterated its expectation the new injection will deliver 25% weight loss.…
English